Literature DB >> 27170749

Both CD8+ and CD4+ T Cells Contribute to Corneal Clouding and Viral Clearance following Vaccinia Virus Infection in C57BL/6 Mice.

I V Larsen1, H Clausius1, A W Kolb1, C R Brandt2,3,4.   

Abstract

UNLABELLED: Vaccinia virus (VACV) keratitis is a serious complication following smallpox vaccination and can lead to blindness. The pathological mechanisms involved in ocular VACV infection are poorly understood. Previous studies have used rabbits, but the lack of immune reagents and transgenic or knockout animals makes them less suitable for mechanistic studies. We report that infection of C57BL/6 mice with 1 × 10(7) PFU of vaccinia virus strain WR results in blepharitis, corneal neovascularization, and stromal keratitis. The DryVax strain of VACV was completely attenuated. Infection required corneal scarification and replication-competent virus, and the severity of ocular disease was similar in 4- to 6-week-old and 1-year-old mice. Viral titers peaked at approximately 1 × 10(6) PFU on day 5 postinfection, and virus had not cleared by day 13 postinfection. Neutrophils were found in the peripheral cornea on day 1 after infection and then declined, followed by infiltration of both CD4(+) and CD8(+) T cells, which remained peripheral throughout the infection. Blood vessel growth extended 2 to 5 mm into the cornea from the limbus. Infection of CD4(-/-), CD8(-/-), or antibody-depleted mice resulted in similar disease severity and corneal clouding, indicating that both T-cell subsets were involved in the immunopathological response. Depletion of both CD4(+) and CD8(+) T cells resulted in significantly more severe disease and failure to clear the virus. On the basis of our results, the pathology of VACV keratitis is significantly different from that of herpes simplex virus keratitis. Further studies are likely to reveal novel information regarding virulence and immune responses to viral ocular infection. IMPORTANCE: Potentially blinding eye infections can occur after vaccination for smallpox. Very little is known about the pathological mechanisms that are involved, and the information that is available was generated using rabbit models. The lack of immunological reagents for rabbits makes such studies difficult. We characterized a mouse model of vaccinia virus ocular disease using C57BL/6 mice and strain WR and show that both CD4(+) and CD8(+) T-cell subsets play a role in the blinding eye disease and in controlling virus replication. On the basis of these results, vaccinia virus keratitis is significantly different from herpes simplex virus keratitis, and further studies using this model should generate novel insights into immunopathological responses to viral ocular infection.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27170749      PMCID: PMC4936152          DOI: 10.1128/JVI.00570-16

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

1.  Herpes simplex virus stromal keratitis is not titer-dependent and does not correlate with neurovirulence.

Authors:  D R Grau; R J Visalli; C R Brandt
Journal:  Invest Ophthalmol Vis Sci       Date:  1989-12       Impact factor: 4.799

2.  Evaluation of therapeutic interventions for vaccinia virus keratitis.

Authors:  Sharon Altmann; Curtis R Brandt; Christopher J Murphy; Ravi Patnaikuni; Teresa Takla; Megan Toomey; Brittany Nesbit; Kimberly McIntyre; Jill Covert; Richard Dubielzig; Gary Leatherberry; Elizabeth Adkins; Shantha Kodihalli
Journal:  J Infect Dis       Date:  2011-01-28       Impact factor: 5.226

3.  Identification of 10 cowpox virus proteins that are necessary for induction of hemorrhagic lesions (red pocks) on chorioallantoic membranes.

Authors:  Zhiyong Xu; Dimitrios Zikos; Aistė Tamošiūnaitė; Robert Klopfleisch; Nikolaus Osterrieder; B Karsten Tischer
Journal:  J Virol       Date:  2014-05-21       Impact factor: 5.103

4.  On the essential involvement of neutrophils in the immunopathologic disease: herpetic stromal keratitis.

Authors:  J Thomas; S Gangappa; S Kanangat; B T Rouse
Journal:  J Immunol       Date:  1997-02-01       Impact factor: 5.422

5.  A model for vaccinia virus pathogenesis and immunity based on intradermal injection of mouse ear pinnae.

Authors:  David C Tscharke; Geoffrey L Smith
Journal:  J Gen Virol       Date:  1999-10       Impact factor: 3.891

6.  CD8 T cells are essential for recovery from a respiratory vaccinia virus infection.

Authors:  John Goulding; Rebecka Bogue; Vikas Tahiliani; Michael Croft; Shahram Salek-Ardakani
Journal:  J Immunol       Date:  2012-07-23       Impact factor: 5.422

7.  A quantitative rabbit model of vaccinia keratitis.

Authors:  Sharon Altmann; Andrew Emanuel; Megan Toomey; Kim McIntyre; Jill Covert; Richard Redd Dubielzig; Gary Leatherberry; Christopher J Murphy; Shantha Kodihalli; Curtis R Brandt
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-04-07       Impact factor: 4.799

Review 8.  Working safely with vaccinia virus: laboratory technique and review of published cases of accidental laboratory infections.

Authors:  Stuart N Isaacs
Journal:  Methods Mol Biol       Date:  2012

Review 9.  Pathogenesis of herpes stromal keratitis--a focus on corneal neovascularization.

Authors:  Fernanda Giménez; Amol Suryawanshi; Barry T Rouse
Journal:  Prog Retin Eye Res       Date:  2012-08-07       Impact factor: 21.198

10.  Dermal infection with vaccinia virus reveals roles for virus proteins not seen using other inoculation routes.

Authors:  David C Tscharke; Patrick C Reading; Geoffrey L Smith
Journal:  J Gen Virol       Date:  2002-08       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.